Niek F. Casteleijn

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease

Esther Meijer, Folkert W. Visser, R. Aerts et al. · JAMA · 2018 · 102 citations · Full text

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease

R. Aerts, Wietske Kievit, Hedwig M. A. D‘Agnolo et al. · Gastroenterology · 2019 · 82 citations · Full text

Urology, Hepatology, Medicine +9

Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease

Esther Meijer, Joost P.H. Drenth, Hedwig M. A. D‘Agnolo et al. · American Journal of Kidney Diseases · 2013 · 70 citations · Full text

Urology, Medicine, Kidney Failure +8

Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression

A. Lianne Messchendorp, Esther Meijer, Wendy E. Boertien et al. · Kidney International Reports · 2017 · 48 citations · Full text

Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial

Niek F. Casteleijn, Jaime D. Blais, Arlene B. Chapman et al. · American Journal of Kidney Diseases · 2016 · 46 citations · Full text